Quarterly sales of Novo Nordisks Wegovy in 2022 and 2024, Statista (2024) Contrave, DailyMed (2024) Wegovy, DailyMed (2024) Prescription medications to treat overweight & obesity, National Institute of Diabetes and Digestive and Kidney Diseases (2024) Why obesity is a disease, Obesity Medicine Association (2023) AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity, Gastroenterology (2022) Naltrexone/bupropion ER (Contrave), Pharmacy & Therapeutics (2016) Once-weekly semaglutide in adults with overweight or obesity, New England Journal of Medicine (2021) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Yancopoulos, MD, PhD, board co-chair, president, chief scientific officer, Regeneron, in a press release
Where do they differ in side effects
Tirzepatide is the active ingredient in two FDA-approved brand-name injectable drugs